Positionspapier der Deutschen Hauptstelle für Suchtfragen: Versorgung und Behandlung Opioidabhängiger mit Diamorphin Einleitung Nach mehr als vierzehn Jahren der praktischen Erfahrung mit der Diamorphinbehandlung in der Regelversorgung gibt es e...

Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma.  Thomann J, Vogt SB, Guessoum A, Meyer...

Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.  Myklebust LH, Eide D, Arnevik EA, Dadras O, De Pirro S, Ellefsen R, Fadnes LT, Hesse M, Kvamme TL, Melis F, Oldervoll A, Thylstrup B, Wusthoff LEC, Claus...

Long access heroin self-administration significantly alters gut microbiome composition and structure.  Greenberg JM, Winters AD, Zagorac B, Kracht DJ, Francescutti DM, Cannella N, Ciccocioppo R, Woods LCS, Mackle J, Hardiman GT, Kuhn BN, Kal...

Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK.  Poulter HL, Moore HJ, Ahmed D, Riley F, Walker T, Harris M.  Int J Dru...

Webinar. Hydromorphone for Opioid Use Disorder: Insights from the Feasibility of Opioid Injecting Trial Penington Institute invites you to join us for a discussion featuring an expert panel on the trial of short-acting injectable opioid treatment...